Koyfin Home > Directory > Health Care > Amphastar Pharma > EV / Sales (ntm)

Amphastar Pharma EV / Sales (ntm) Chart (AMPH)

Amphastar Pharma annual/quarterly EV / Sales (ntm) from 2014 to 2018.
  • Amphastar Pharma EV / Sales (ntm) for the quarter ending March 03, 2018 was 2.86 a -1.50% decrease of -0.04 year over year
  • Amphastar Pharma Annual EV / Sales (ntm) for 2017 was 3.08 a 2.56% increase of 0.08 from 2016
  • Amphastar Pharma Annual EV / Sales (ntm) for 2016 was 3.00 a 19.36% increase of 0.58 from 2015
  • Amphastar Pharma Annual EV / Sales (ntm) for 2015 was 2.42 a 9.21% increase of 0.22 from 2014
Other Valuation Metrics:
  • Amphastar Pharma Market Cap for the quarter ending March 03, 2018 was $869m a 6.01% increase of 52m year over year
  • Amphastar Pharma Price / Book for the quarter ending March 03, 2018 was 2.59 a 2.71% increase of 0.07 year over year
  • Amphastar Pharma Enterprise Value for the quarter ending March 03, 2018 was $848m a 8.52% increase of 72m year over year
View Chart On Koyfin

Quarterly AMPH EV / Sales (ntm) Data

03/20182.86
12/20173.08
09/20173.00
06/20172.90
03/20172.23
12/20163.00
09/20163.05
06/20162.62
03/20161.94
12/20152.42

Annual AMPH EV / Sales (ntm) Data

20173.08
20163.00
20152.42
20142.20